首页> 外国专利> Oral dosage form, process for making the dosage form, use of oral pharmaceutical dosage form, and methods to increase inhibition of gastric acid secretion and to increase the therapeutic effect in the treatment of gastrointestinal disorders associated with excess acid secretion

Oral dosage form, process for making the dosage form, use of oral pharmaceutical dosage form, and methods to increase inhibition of gastric acid secretion and to increase the therapeutic effect in the treatment of gastrointestinal disorders associated with excess acid secretion

机译:口服剂型,制备剂型的方法,口服药物剂型的使用以及增加对胃酸分泌的抑制作用并提高与过量酸分泌有关的胃肠道疾病的治疗效果的方法

摘要

"ORAL DOSAGE FORM, PROCESS FOR THE MANUFACTURE OF DOSAGE FORM, USE OF ORAL PHARMACEUTICAL DOSAGE FORM, AND, METHODS TO INCREASE GASTIC ACID SECRETATION INHIBITION AND TO INCREASE THE THERAPEUTIC EFFECT IN THE TREATMENT OF DISTORIATED GASTRIC TESTATION. ACID ". Oral dosage form comprising core material coated with semipermeable membrane in which the core material comprises active ingredient selected from the group of omeprazole, alkaline salt thereof, S-omeprazole and alkaline salt thereof, in mixture with one or more alkaline additives, one or more swelling agents, and optionally pharmaceutically acceptable excipients, and the dosage form has no enteric coating.
机译:“口服剂量形式,剂量形式的制备过程,口服药物剂量形式的使用,以及增加胃酸分泌抑制和增加治疗畸形胃测试的方法的方法。酸。”包含经半透膜包衣的核心材料的口服剂型,其中核心材料包含选自奥美拉唑,其碱性盐,S-奥美拉唑及其碱性盐的活性成分,与一种或多种碱性添加剂混合,一种或多种溶胀剂和任选的药学上可接受的赋形剂,并且剂型没有肠溶衣。

著录项

  • 公开/公告号TR200103693T2

    专利类型

  • 公开/公告日2002-05-21

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号TR20010003693T

  • 发明设计人 PER JOHAN LUNDBERG;BRITA SJOEBLOM;

    申请日2000-06-20

  • 分类号A61K9/36;

  • 国家 TR

  • 入库时间 2022-08-22 00:43:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号